| Colorectal cancer in Saudi Arabia: incidence, survival, demographics and implications for national policies N Alsanea, AS Abduljabbar, S Alhomoud, LH Ashari, D Hibbert, ... Annals of Saudi medicine 35 (3), 196-202, 2015 | 171 | 2015 |
| Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy S Uddin, M Ahmed, A Hussain, J Abubaker, N Al-Sanea, A AbdulJabbar, ... The American journal of pathology 178 (2), 537-547, 2011 | 169 | 2011 |
| HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer K Al-Kuraya, H Novotny, P Bavi, AK Siraj, S Uddin, A Ezzat, N Al Sanea, ... Journal of clinical pathology 60 (7), 768-772, 2007 | 150 | 2007 |
| The cutting seton: an experience at King Faisal Specialist Hospital WH Isbister, N Al Sanea Diseases of the colon & rectum 44, 722-727, 2001 | 139 | 2001 |
| Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population J Abubaker, P Bavi, S Al-Harbi, M Ibrahim, AK Siraj, N Al-Sanea, ... Oncogene 27 (25), 3539-3545, 2008 | 129 | 2008 |
| Prognostic significance of alterations in KRAS isoforms KRAS‐4A/4B and KRAS mutations in colorectal carcinoma J Abubaker, P Bavi, W Al‐Haqawi, M Sultana, S Al‐Harbi, N Al‐Sanea, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 98 | 2009 |
| Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer S Uddin, M Ahmed, P Bavi, R El-Sayed, N Al-Sanea, A AbdulJabbar, ... Cancer research 68 (9), 3379-3388, 2008 | 89 | 2008 |
| Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs) HA Hakeam, N Al-Sanea Journal of thrombosis and thrombolysis 43, 343-351, 2017 | 83 | 2017 |
| Role of Nigella sativa and a number of its antioxidant constituents towards azoxymethane‐induced genotoxic effects and colon cancer in rats D Al‐Johar, N Shinwari, J Arif, N Al‐Sanea, AA Jabbar, R El‐Sayed, ... Phytotherapy Research: An International Journal Devoted to Pharmacological …, 2008 | 82 | 2008 |
| National guidelines for colorectal cancer screening in Saudi Arabia with strength of recommendations and quality of evidence: tripartite task force from Saudi Society of Colon … N Alsanea, MA Almadi, AS Abduljabbar, S Alhomoud, TA Alshaban, ... Annals of Saudi Medicine 35 (3), 189-195, 2015 | 81 | 2015 |
| Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinoma P Bavi, S Uddin, M Ahmed, Z Jehan, R Bu, J Abubaker, M Sultana, ... The American journal of pathology 178 (5), 2109-2120, 2011 | 71 | 2011 |
| Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication S Uddin, P P. Bavi, AR Hussain, G Alsbeih, N Al-Sanea, A AbdulJabbar, ... Carcinogenesis 30 (11), 1832-1840, 2009 | 68 | 2009 |
| Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer Z Jehan, P Bavi, M Sultana, J Abubaker, R Bu, A Hussain, G Alsbeih, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 61 | 2009 |
| High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target S Uddin, AR Hussain, M Ahmed, J Abubaker, N Al-Sanea, A AbdulJabbar, ... Official journal of the American College of Gastroenterology| ACG 104 (7 …, 2009 | 52 | 2009 |
| A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma AK Siraj, R Bu, S Prabhakaran, P Bavi, S Beg, M Al Hazmi, M Al-Rasheed, ... Molecular Cancer 13, 1-9, 2014 | 49 | 2014 |
| Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer AK Siraj, S Prabhakaran, P Bavi, R Bu, S Beg, MA Hazmi, M Al‐Rasheed, ... Cancer 121 (11), 1762-1771, 2015 | 42 | 2015 |
| ALK gene amplification is associated with poor prognosis in colorectal carcinoma P Bavi, Z Jehan, R Bu, S Prabhakaran, N Al-Sanea, F Al-Dayel, ... British journal of cancer 109 (10), 2735-2743, 2013 | 42 | 2013 |
| POSSUM: A re‐evaluation in patients undergoing surgery for rectal cancer WH Isbister, N Al Sanea ANZ Journal of Surgery 72 (6), 421-425, 2002 | 40 | 2002 |
| Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells M Ahmed, AR Hussain, AK Siraj, S Uddin, N Al-Sanea, F Al-Dayel, ... Molecular cancer 14, 1-14, 2015 | 39 | 2015 |
| Evaluation of the cutting seton as a method of treatment for perianal fistula SM Raslan, M Aladwani, N Alsanea Annals of Saudi medicine 36 (3), 210-215, 2016 | 33 | 2016 |
